Table 1:

Pre-, peri- and postoperative characteristic of patients in study group

Data, n = 13 337
Preoperative
 Age (years)64.911 (65.6), [58.9–71.6]
 Female, % (n)19.6 (2614)
 Body mass index (kg/m2)28.4, (27.9), [25.4–30.9]
 Heart failure, % (n)0.14 (19)
 Critical preoperative state, % (n)0.13 (17)
 Previous cerebral vascular accident, % (n)1 (133)
 Diabetes, % (n)36.7 (4895)
 Preoperative dialysis, % (n)0.4 (53)
 Previous myocardial infarction, % (n)48.9 (6522)
 Peripheral vascular disease, % (n)13.6 (1814)
 Hypertension, % (n)60.1 (802)
 Chronic obstructive pulmonary disease, % (n)
  None79.5 (10 603)
  Mild7.7 (1027)
  Moderate10.9 (1454)
  Severe1.9 (253)
 Type of lung disease, % (n)
  None85.0 (11 336)
  Obstructive13.2 (1757)
  Restrictive1.0 (133)
  Mixed0.8 (111)
 FEV1, %90, (93.0), [79.2–100]
 Preoperative IABP, % (n)1.3 (173)
 Ejection fraction
  Good, % (n)59.7 (7962)
  Moderate, % (n)31.4 (4188)
  Poor, % (n)8.9 (1187)
 Previous PCI, % (n)6.4 (854)
 Status
  Elective, % (n)80.5 (10 736)
  Urgent, % (n)18.2 (2428)
  Emergency, % (n)1.3 (173)
 Log EuroSCORE4.7, (2.6), [1.5–5.0]
Operative
 Left internal mammary artery, % (n)91.9 (12 257)
 Number of grafts3.4, (3.0), [3–4]
 Cardiopulmonary bypass time (min)109, (106), [88–127]
Postoperative
 Creatinine kinase myocardial isoenzyme30.3, (15), [4–34]
 Intensive care length of stay (days)2.2, (1), [1–2]
 Hospital length of stay (days)9.5 (7.0) [6–9]
 Mortality, % (n)2.1 (280)
 Median follow-up (years)7.02
Data, n = 13 337
Preoperative
 Age (years)64.911 (65.6), [58.9–71.6]
 Female, % (n)19.6 (2614)
 Body mass index (kg/m2)28.4, (27.9), [25.4–30.9]
 Heart failure, % (n)0.14 (19)
 Critical preoperative state, % (n)0.13 (17)
 Previous cerebral vascular accident, % (n)1 (133)
 Diabetes, % (n)36.7 (4895)
 Preoperative dialysis, % (n)0.4 (53)
 Previous myocardial infarction, % (n)48.9 (6522)
 Peripheral vascular disease, % (n)13.6 (1814)
 Hypertension, % (n)60.1 (802)
 Chronic obstructive pulmonary disease, % (n)
  None79.5 (10 603)
  Mild7.7 (1027)
  Moderate10.9 (1454)
  Severe1.9 (253)
 Type of lung disease, % (n)
  None85.0 (11 336)
  Obstructive13.2 (1757)
  Restrictive1.0 (133)
  Mixed0.8 (111)
 FEV1, %90, (93.0), [79.2–100]
 Preoperative IABP, % (n)1.3 (173)
 Ejection fraction
  Good, % (n)59.7 (7962)
  Moderate, % (n)31.4 (4188)
  Poor, % (n)8.9 (1187)
 Previous PCI, % (n)6.4 (854)
 Status
  Elective, % (n)80.5 (10 736)
  Urgent, % (n)18.2 (2428)
  Emergency, % (n)1.3 (173)
 Log EuroSCORE4.7, (2.6), [1.5–5.0]
Operative
 Left internal mammary artery, % (n)91.9 (12 257)
 Number of grafts3.4, (3.0), [3–4]
 Cardiopulmonary bypass time (min)109, (106), [88–127]
Postoperative
 Creatinine kinase myocardial isoenzyme30.3, (15), [4–34]
 Intensive care length of stay (days)2.2, (1), [1–2]
 Hospital length of stay (days)9.5 (7.0) [6–9]
 Mortality, % (n)2.1 (280)
 Median follow-up (years)7.02

Continuous variables are shown as mean, (median) [25th–75th interquartile range]. Categorical variables are shown as a percentage (n).

IABP: intra-aortic balloon pump; PCI: percutaneous coronary intervention.

Table 1:

Pre-, peri- and postoperative characteristic of patients in study group

Data, n = 13 337
Preoperative
 Age (years)64.911 (65.6), [58.9–71.6]
 Female, % (n)19.6 (2614)
 Body mass index (kg/m2)28.4, (27.9), [25.4–30.9]
 Heart failure, % (n)0.14 (19)
 Critical preoperative state, % (n)0.13 (17)
 Previous cerebral vascular accident, % (n)1 (133)
 Diabetes, % (n)36.7 (4895)
 Preoperative dialysis, % (n)0.4 (53)
 Previous myocardial infarction, % (n)48.9 (6522)
 Peripheral vascular disease, % (n)13.6 (1814)
 Hypertension, % (n)60.1 (802)
 Chronic obstructive pulmonary disease, % (n)
  None79.5 (10 603)
  Mild7.7 (1027)
  Moderate10.9 (1454)
  Severe1.9 (253)
 Type of lung disease, % (n)
  None85.0 (11 336)
  Obstructive13.2 (1757)
  Restrictive1.0 (133)
  Mixed0.8 (111)
 FEV1, %90, (93.0), [79.2–100]
 Preoperative IABP, % (n)1.3 (173)
 Ejection fraction
  Good, % (n)59.7 (7962)
  Moderate, % (n)31.4 (4188)
  Poor, % (n)8.9 (1187)
 Previous PCI, % (n)6.4 (854)
 Status
  Elective, % (n)80.5 (10 736)
  Urgent, % (n)18.2 (2428)
  Emergency, % (n)1.3 (173)
 Log EuroSCORE4.7, (2.6), [1.5–5.0]
Operative
 Left internal mammary artery, % (n)91.9 (12 257)
 Number of grafts3.4, (3.0), [3–4]
 Cardiopulmonary bypass time (min)109, (106), [88–127]
Postoperative
 Creatinine kinase myocardial isoenzyme30.3, (15), [4–34]
 Intensive care length of stay (days)2.2, (1), [1–2]
 Hospital length of stay (days)9.5 (7.0) [6–9]
 Mortality, % (n)2.1 (280)
 Median follow-up (years)7.02
Data, n = 13 337
Preoperative
 Age (years)64.911 (65.6), [58.9–71.6]
 Female, % (n)19.6 (2614)
 Body mass index (kg/m2)28.4, (27.9), [25.4–30.9]
 Heart failure, % (n)0.14 (19)
 Critical preoperative state, % (n)0.13 (17)
 Previous cerebral vascular accident, % (n)1 (133)
 Diabetes, % (n)36.7 (4895)
 Preoperative dialysis, % (n)0.4 (53)
 Previous myocardial infarction, % (n)48.9 (6522)
 Peripheral vascular disease, % (n)13.6 (1814)
 Hypertension, % (n)60.1 (802)
 Chronic obstructive pulmonary disease, % (n)
  None79.5 (10 603)
  Mild7.7 (1027)
  Moderate10.9 (1454)
  Severe1.9 (253)
 Type of lung disease, % (n)
  None85.0 (11 336)
  Obstructive13.2 (1757)
  Restrictive1.0 (133)
  Mixed0.8 (111)
 FEV1, %90, (93.0), [79.2–100]
 Preoperative IABP, % (n)1.3 (173)
 Ejection fraction
  Good, % (n)59.7 (7962)
  Moderate, % (n)31.4 (4188)
  Poor, % (n)8.9 (1187)
 Previous PCI, % (n)6.4 (854)
 Status
  Elective, % (n)80.5 (10 736)
  Urgent, % (n)18.2 (2428)
  Emergency, % (n)1.3 (173)
 Log EuroSCORE4.7, (2.6), [1.5–5.0]
Operative
 Left internal mammary artery, % (n)91.9 (12 257)
 Number of grafts3.4, (3.0), [3–4]
 Cardiopulmonary bypass time (min)109, (106), [88–127]
Postoperative
 Creatinine kinase myocardial isoenzyme30.3, (15), [4–34]
 Intensive care length of stay (days)2.2, (1), [1–2]
 Hospital length of stay (days)9.5 (7.0) [6–9]
 Mortality, % (n)2.1 (280)
 Median follow-up (years)7.02

Continuous variables are shown as mean, (median) [25th–75th interquartile range]. Categorical variables are shown as a percentage (n).

IABP: intra-aortic balloon pump; PCI: percutaneous coronary intervention.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close